What You Should Know:
– Interwell Health, the leading physician organization driving innovation in the renal industry, announced the closing of a Series B round of equity funding of over $46 million, expanding Interwell’s investor group of premier, visionary nephrology practices across the country.
– Through its network of more than 1,400 nephrologist network participants, and its partnership with Fresenius Medical Care North America (FMCNA), InterWell Health deploys a broad scope of data-driven and clinically proven tools to effectively identify and manage chronic disease for the vulnerable renal patient population.
– This private offering will help the company deliver value-based care arrangements that provide support to chronic kidney disease (CKD) patients across the full continuum of care to improve patients’ outcomes and quality of life.
